Physician profile
Trisha Zeidan
NPI 1679695985
$124,415.35
in general payments reported to CMS, 2019-2025
21 companies · $2,178 in 2025
The $2,178 reported for 2025 was more than what 78% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21K · 2020: $18K · 2021: $11K · 2022: $23K · 2023: $49K · 2024: $122 · 2025: $2,178.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $45K · Food and Beverage: $3,268 · Travel and Lodging: $3,028 · Education: $64.26 · Long Term Medical Supply Or Device Loan: $49.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $44,914.00 |
| Food and Beverage | $3,268.22 |
| Travel and Lodging | $3,028.11 |
| Education | $64.26 |
| Long Term Medical Supply Or Device Loan | $49.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $57,306.65 | 2019-2025 | Mounjaro, Zepbound |
| Novo Nordisk INC | $25,291.88 | 2019-2025 | Ozempic, Rybelsus |
| Valeritas, INC. | $9,915.52 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $9,866.53 | 2019-2025 | Jardiance |
| Zealand Pharma US, INC. | $6,996.95 | 2020-2022 | |
| Mannkind Corporation | $6,735.87 | 2023 | V-Go |
| Abbott Laboratories | $3,265.72 | 2019-2025 | Freestyle Libre 3, Freestyle Insulinx |
| Corcept Therapeutics | $1,915.43 | 2019-2023 | Korlym |
| Cequr Corporation | $1,232.88 | 2022-2025 | Cequr Simplicity |
| Beta Bionics, INC. | $522.45 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Medtronic, INC. | $354.90 | 2022-2025 | Minimed 780g |
| Xeris Pharmaceuticals, INC. | $228.56 | 2024-2025 | Gvoke Hypopen |
| Bayer Healthcare Pharmaceuticals INC. | $202.91 | 2022-2023 | |
| Astrazeneca Pharmaceuticals Lp | $173.43 | 2021-2022 | |
| Dexcom, INC. | $150.05 | 2025 | Dexcom G6 Transmitter |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tandem Diabetes Care, INC. | $70.38 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Amgen INC. | $69.49 | 2025 | Evenity, Repatha |
| Amphastar Pharmaceuticals, INC. | $41.98 | 2025 | |
| Insulet Corporation | $35.96 | 2023-2025 | Omnipod |
| Alexion Pharmaceuticals, INC. | $20.06 | 2025 | Strensiq |
| Ascensia Diabetes Care US INC. | $17.75 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Trisha Zeidan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.